BMX and glioma: Mechanistically, BMX bypasses the suppressor of cytokine signaling 3 (SOCS3)-mediated inhibition of JAK2, whereas targeting of the BMX dampens the JAK2-mediated STAT3 activation, underlying a new molecular basis in which to specifically eliminate the glioma stem cells [29].